BackgroundIVD is a key enzyme in leucine catabolism, catalyzing the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The model enables the study of the fundamental interactions that underlie neurodegenerative disease. Researchers from Northwestern University and the University of California, Santa Barbara have ...

Deep Apple Therapeutics, Inc. announced on Wednesday a research collaboration and exclusive worldwide license agreement with ...

In this week’s Science for All newsletter, Manaswini Vijayakumar breaks down an experiment that allowed scientists to see the ...

In this week’s Science for All newsletter, Manaswini Vijayakumar breaks down an experiment that allowed scientists to see the ...

SLC35B1 transports ATP into the ER, and its structure offers potential for targeted therapies in diseases linked to ER stress ...

Deep Apple Therapeutics, Inc. has announced a research collaboration and exclusive worldwide license agreement with Novo ...

Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.